(Q48726206)

15 February 2018

title

Effects of antidepressants on phencyclidine-induced enhancement of immobility in a forced swimming test in mice. (English)

1 reference

15 February 2018

author name string

Noda Y

1

1 reference

15 February 2018

Mamiya T

2

1 reference

15 February 2018

Furukawa H

3

1 reference

15 February 2018

Nabeshima T

4

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 April 1997

1 reference

15 February 2018

European Journal of Pharmacology

published in

1 reference

15 February 2018

volume

324

1 reference

15 February 2018

issue

2-3

1 reference

15 February 2018

page(s)

135-140

1 reference

15 February 2018

Psychotic reactions during amitriptyline therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

The nature and prevalence of depression in chronic schizophrenic in-patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Role of the serotonergic system in the forced swimming test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Comparison of desipramine, amitriptyline, zimeldine and alaproclate in six animal models used to investigate antidepressant drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Testing systems for assessment of negative symptoms in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Glycine potentiates N-methyl-D-aspartate-induced [3H]TCP binding to rat cortical membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

[Negative schizophrenic symptoms and their detection]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Effects of MK-801 and antidepressant drugs in the forced swimming test in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Effects of mianserin in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Depression: a new animal model sensitive to antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Behavioural despair in rats: A new model sensitive to antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Effects of NMDA receptor antagonists and sigma ligands on the acquisition of conditioned fear in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Use of Antidepressant Drugs in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Withdrawal from chronic phencyclidine (PCP) dependence with desipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Negative symptoms and visual behavior in DSM-III-R prognostic subtypes of schizophreniform disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

Neuropsychiatric disorders: investigation of schizophrenia and substance abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

New pharmacotherapeutic modalities for negative symptoms in psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900067-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(97)00067-8

1 reference

15 February 2018

release_ozuuyhhnunc3np2sc3szygi6xe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ozuuyhhnunc3np2sc3szygi6xe

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9145763

1 reference

15 February 2018